Stockreport

Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day

Longeveron Inc. - Class A Common stock  (LGVN) 
PDF MIAMI, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for [Read more]